KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Asset Writedowns and Impairment (2019 - 2024)

Twist Bioscience has reported Asset Writedowns and Impairment over the past 6 years, most recently at $293000.0 for Q3 2024.

  • Quarterly Asset Writedowns and Impairment fell 80.89% to $293000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $940000.0 through Sep 2024, down 63.47% year-over-year, with the annual reading at -$20000.0 for FY2025, 102.13% down from the prior year.
  • Asset Writedowns and Impairment was $293000.0 for Q3 2024 at Twist Bioscience, up from $144000.0 in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $17.5 million in Q3 2022 and troughed at -$1.0 million in Q2 2020.
  • The 5-year median for Asset Writedowns and Impairment is $332000.0 (2023), against an average of $1.3 million.
  • Year-over-year, Asset Writedowns and Impairment surged 1379.41% in 2022 and then tumbled 91.26% in 2023.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $248000.0 in 2020, then soared by 373.39% to $1.2 million in 2021, then crashed by 78.36% to $254000.0 in 2022, then fell by 2.36% to $248000.0 in 2023, then rose by 18.15% to $293000.0 in 2024.
  • Per Business Quant, the three most recent readings for TWST's Asset Writedowns and Impairment are $293000.0 (Q3 2024), $144000.0 (Q2 2024), and $255000.0 (Q1 2024).